Results 81 to 90 of about 14,229 (206)

HEPATORENAL SYNDROME

Zdravniški Vestnik, 2001
Background. Hepatorenal syndrome (HRS) is acommon complication of advanced hepatic disease characterizedby marked abnormalities in arterial circulation and byrenal failure. An extreme arteriolar vasodilatation located inthe splanchnic circulation results
Matjaž Hafner
doaj  

Type 1 Hepatorenal Syndrome

, 2016
Type 1 hepatorenal syndrome is kidney failure that occurs in advanced cirrhosis (Fagundes & Ginès, 2012). It is characterized by a, “significant reduction in creatinine clearance within 1-2 weeks of presentation” (Bacon, 2015). Patients that develop this
Evans, Ernest
core   +1 more source

Terlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives

, 2011
Type 1 hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Type 1 HRS develops as the consequence of a severe reduction of effective circulating volume due to both extreme splanchnic arterial
P. Angeli, Angeli P.
core   +1 more source

Principles of portal hypertension treatment at patients with liver cirrhosis

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2012
The aim of review. To describe modern principles of portal hypertension treatment in patients with liver cirrhosis (LC).Original positions. One of the most significant LC complications is portal hypertension - acute bleeding from varicose veins (VV) of ...
Ye. A. Fedosina, M. V. Mayevskaya, V. T. Ivashkin   +2 more
doaj  

Cardiac Output Changes in Hepatorenal Syndrome

, 2020
Background: Recent studies suggest that the development of hepatorenal syndrome occurs in the setting of a reduction in cardiac output, indicating that the progression of circulatory and renal dysfunction in cirrhosis is caused not only by splanchnic ...
Khaled El Karmouty, Reham Al Swaff, Nanees Adel, Eman Elbedwehy   +3 more
core  

Terlipressin versus other vasoactive drugs for hepatorenal syndrome [PDF]

, 2017
Background: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal ...
Goldin, Alison H., Aleksander Krag, Israelsen, Mads, Alison H Goldin, Manol Jovani, Allegretti, Andrew S., Krag, Aleksander, Gluud, Lise Lotte, Lise Lotte Gluud, Jovani, Manol, Rachel W Winter, Mads Israelsen, Winter, Rachel W., Andrew S Allegretti, Krag, Aleksander; id_orcid   +14 more
core   +1 more source

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY

Pakistan Armed Forces Medical Journal, 2019
Objective: To compare the efficacy of noradrenaline and terlipressin in hepatorenal syndrome. Study Design: Randomized controlled trial. Place and Duration of Study: Combined Military Hospital Lahore, from May 2018 to Jan 2019.
Muhammad Siddique, Mansoor Ud Din Sajid, Omar Ahsan   +2 more
doaj  

Diagnostic and prognostic value of Doppler ultrasound study in hepatorenal syndrome. A report of a case

Acta Médica del Centro, 2016
Hepatorenal syndrome is a condition that occurs in patients with chronic liver disease characterized by portal hypertension and it is distinguished by the deterioration of renal function and marked abnormalities in blood circulation, with activation of ...
Raysa Garay Padrón, Milagros Hernández Fernández, Arai Peña Bernal   +2 more
doaj  

A STUDY OF HYPONATREMIA IN PATIENTS OF LIVER CIRRHOSIS IN A TERTIARY CARE HOSPITAL OF SOUTH GUJARAT

National Journal of Medical Research, 2021
Introduction: Hyponatremia is the most common electrolyte abnormality in patients with liver cirrhosis and associates with the poor prognosis and the complications like hepatorenal syndrome, ascites etc.
Urvi B Patel, Tusharbhai J Kanani, Dipika A Patel   +2 more
doaj  

Serum microRNA-122 predicts survival in patients with liver cirrhosis

, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Stefan Zeuzem, Albrecht Piiper (22854), Oliver Waidmann, Kronenberger, Bernd, Friederike Brunner, Verena Köberle (130993), Bernd Kronenberger (131004), Bernd Kronenberger, Verena Köberle, Waidmann, Oliver, Albrecht Piiper, Oliver Waidmann (130988), Piiper, Albrecht, Friederike Brunner (130998), Köberle, Verena, Brunner, Friederike, Zeuzem, Stefan, Stefan Zeuzem (22856)   +17 more
core   +1 more source